All News #Library
Others
ViGeneron Doses First Patient in VG901 Phase 1b Trial
10 Apr 2024 //
GLOBENEWSWIRE
ViGeneron, Daiichi to develop novel gene therapy for prevalent eye diseases
29 Apr 2022 //
BIOSPECTRUMASIA
ViGeneron and Daiichi Sankyo to develop therapy for eye diseases
26 Apr 2022 //
PHARMATIMES
ViGeneron announces follow-on collaboration with Daiichi Sankyo
25 Apr 2022 //
GLOBENEWSWIRE
ViGeneron signs strategic collaboration and option agreement with Regeneron
06 Apr 2022 //
GLOBENEWSWIRE

Market Place
Sourcing Support